NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder

Computer modeling and simulation has become a vital part of the drug development process

Lonza Walkersville’s new Silensomes™ HLM products provide researchers a fully characterized pre-made solution for CYP phenotyping, resulting in more consistent and reliable results

The journey from lead discovery to final approval can be long and challenging

New drugs to treat depression in particular are needed because many existing antidepressants don't work in up to 50 percent of patients

In recent years, researchers have learned more—largely through 3D atomic structures—about how G protein-coupled receptors are built and thus how they function

The team used neutron crystallography to study the location of hydrogen atoms in aspartate aminotransferase, or AAT, an enzyme vital to the metabolism of certain amino acids

A novel and disruptive analysis and monoclonal assurance system for drug discovery and development

Scientists believe that developing drugs that act on multiple targets, called a polypharmacology approach, may more effectively treat those cancers that have a network of alterations

Phoenix 8.0 provides scientists with more power, efficiency and transparency into PK/PD analysis and modeling for regulatory review